Home > Clinical Trials
Check All Search

Saved trials

RECRUITING
NCT05417594
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
695 Enrollment(s)
32 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Advanced Solid Malignancies
COMPLETED
NCT04981041
Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI
602 Enrollment(s)
37 Study location(s)
INTERVENTIONAL (PHASE4)
Acute Coronary Syndrome


Atrial Fibrillation
ACTIVE_NOT_RECRUITING
NCT04128748
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
52 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Acute Myeloid Leukemia


Blasts More Than 10 Percent of Bone Marrow Nucleated Cells


High Risk Myelodysplastic Syndrome


Recurrent Acute Myeloid Leukemia


Recurrent Myelodysplastic Syndrome


Refractory Acute Myeloid Leukemia


Refractory Myelodysplastic Syndrome
RECRUITING
NCT07124000
DESTINY-PANTUMOUR04
100 Enrollment(s)
17 Study location(s)
OBSERVATIONAL (None)
Adenocarcinoma (NOS)


Anal Cancer


Bladder Cancer


Cervical Cancer


Endometrial Cancer


Esophageal Cancer


Gall Bladder Cancer


Gastrointestinal Stromal Tumour


Head and Neck Cancer


Liver Cancer


Melanoma


Mouth Cancer


Nasopharangeal Cancer


Neuroendocrine, Gastrointestinal Cancer


Ovarian Cancer


Pancreatic Cancer


Prostate Cancer


Renal Cell Carcinoma


Salivary Gland Cancer


Sarcoma


Small Cell Lung Cancer


Testicular Cancer


Throat Cancer


Thyroid Cancer


Urethral Cancer


Vaginal Cancer


Vulvar Cancer
COMPLETED
NCT00221754
Pravastatin and Protease Inhibitors in HIV-infected Patients
21 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
HIV Infection


Hypercholesterolemia
COMPLETED
NCT05183178
Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
17,095 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Acute Coronary Syndrome
RECRUITING
NCT02693535
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
4,200 Enrollment(s)
181 Study location(s)
INTERVENTIONAL (PHASE2)
Lymphoma, Non-Hodgkin


Multiple Myeloma


Advanced Solid Tumors
RECRUITING
NCT07022483
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
710 Enrollment(s)
61 Study location(s)
INTERVENTIONAL (PHASE3)
Endometrial Cancer